The landscape of dementia diagnosis has progressed dramatically with the appearance of innovative biomarkers, which includes amyloid PET scans, tau imaging, and blood-based checks that could detect Alzheimer's pathology many years before signs or symptoms emerge. Whilst these technological advances stand for amazing progress in understanding neurodegenerative disorders, they've not https://conciergementalhealthserv32210.uzblog.net/the-enduring-price-of-cognitive-evaluation-for-older-older-people-51724170